Laura Rodriguez Gallego
Direttore/Membro del Consiglio presso Onechain Immunotherapeutics
Profilo
Laura Rodriguez Gallego is currently a Partner at Invivo Capital Partners SGEIC SA, a Board Member at OneChain Immunotherapeutics SL, and a Board Member at Telomere Therapeutics SL.
She completed her undergraduate degree at Universitat Autònoma de Barcelona in 2009, and her graduate and doctorate degrees at the University of Barcelona in 2011 and 2015 respectively.
Posizioni attive di Laura Rodriguez Gallego
| Società | Posizione | Inizio |
|---|---|---|
Invivo Capital Partners SGEIC SA
 Invivo Capital Partners SGEIC SA Investment ManagersFinance Invivo Capital Partners SGEIC SA (Invivo Capital Partners) is a venture capital firm founded in 2019 by Albert Ferrer and Luis Pareras. The firm is headquartered in Barcelona, Spain. | Investitore di Private Equity | 01/01/2018 |
Telomere Therapeutics SL
 Telomere Therapeutics SL Pharmaceuticals: MajorHealth Technology Telomere Technologies provides telomere technology services. The company is headquartered in Spain. | Direttore/Membro del Consiglio | 01/04/2024 |
Onechain Immunotherapeutics
 Onechain Immunotherapeutics Medical SpecialtiesHealth Technology Onechain Immunotherapeutics develops oncological therapeutic tools. The company is based in Barcelona, Spain. The Spanish company was founded in 2020 by Pablo Menéndez. The CEO is Jorge Alemany. | Direttore/Membro del Consiglio | 01/01/2022 |
Formazione di Laura Rodriguez Gallego
| University of Barcelona | Doctorate Degree |
| Universitat Autònoma de Barcelona | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Invivo Capital Partners SGEIC SA
Invivo Capital Partners SGEIC SA Investment ManagersFinance Invivo Capital Partners SGEIC SA (Invivo Capital Partners) is a venture capital firm founded in 2019 by Albert Ferrer and Luis Pareras. The firm is headquartered in Barcelona, Spain. | Finance |
Onechain Immunotherapeutics
Onechain Immunotherapeutics Medical SpecialtiesHealth Technology Onechain Immunotherapeutics develops oncological therapeutic tools. The company is based in Barcelona, Spain. The Spanish company was founded in 2020 by Pablo Menéndez. The CEO is Jorge Alemany. | Health Technology |
Telomere Therapeutics SL
Telomere Therapeutics SL Pharmaceuticals: MajorHealth Technology Telomere Technologies provides telomere technology services. The company is headquartered in Spain. | Health Technology |
- Borsa valori
- Insiders
- Laura Rodriguez Gallego
